09:32 EDT Kala Pharmaceuticals (KALA) trading halted, volatility trading pause
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KALA:
- Kala Pharmaceuticals Halts KPI-012 Development After Trial Failure
- Kala to cease development of KPI-012, evaluate strategic options
- Kala says CHASE Phase 2b KPI-012 trial did not meet primary endpoint
- Kala Pharmaceuticals Sets Date for Annual Meeting
- Strategic Positioning and Trial Design Propel Kala Pharmaceuticals to ‘Buy’ Rating